Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Surgical Revascularization (Bypass Surgery)
Treatment for Lower extremity peripheral arterial disease
Typical Dosage: N/A
Effectiveness
88%
Safety Score
55%
Clinical Trials
9
Participants
30K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
55
DangerousModerateSafe
Treatment Details
Dosage Range
N/A
Time to Effect
Immediate to weeks
Treatment Duration
Single procedure, ongoing monitoring/potential re-interventions
Evidence Quality
MODERATEConfidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$500
Side Effect Mgmt:$500
Total Annual:$6,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$95,000/QALY
QALYs Gained
0.45
Outcome-Based Costs
Cost per Responder
$7,059
Cost per Remission
$8,000
Comparison vs Endovascular Revascularization
Cost Difference
+$1,000/year
More expensive
QALY Difference
+0.10 QALYs
Better outcomes
Dominance
No dominance
Surgical Revascularization (Bypass Surgery) Outcomes
for Lower extremity peripheral arterial disease
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
2 active trials recruiting for Surgical Revascularization (Bypass Surgery) in Lower extremity peripheral arterial disease
Prospective Case-control Study in Patients With PAA
NCT04188808RECRUITINGNA
130 participants
INTERVENTIONAL
Gothenburg, Sweden +1 more
Started: Sep 1, 2018
Efficacy and Safety of the Regulatory Polypeptides in Patients With Peripheral Atherosclerosis.
NCT05933720RECRUITINGNA
120 participants
INTERVENTIONAL
Ryazan, Russia
Started: Apr 1, 2023
Completed Clinical Trials
4 completed trials for Surgical Revascularization (Bypass Surgery) in Lower extremity peripheral arterial disease
IDOMENEO - Is Treatment Reality in Vascular Medicine Evidence-based and Follows Guideline Recommendations? A Project for Quality Development Exemplified by Peripheral Arterial Disease (PAD)
NCT03098290COMPLETED
5.61K participants
OBSERVATIONAL
Bad Berka, Germany +34 more
Started: May 1, 2018
Revascularization With Open Bypass Versus Angioplasty and STenting of the Lower Extremity Trial (ROBUST)
NCT01602159COMPLETEDNA
29 participants
INTERVENTIONAL
Baltimore, United States +1 more
Started: Jul 1, 2009
Medium-term Results of Lower Limb Arterial Bypass
NCT07093632COMPLETED
57 participants
OBSERVATIONAL
Lyon, France
Started: Jan 1, 2025
Registry of First-line Treatments in Patients With Critical Limb Ischemia
NCT01877252COMPLETED
1.2K participants
OBSERVATIONAL
Münster, Germany
Started: Jan 1, 2013